These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 26261077)
1. The impact of donor characteristics on the immune cell composition of mixture allografts of granulocyte-colony-stimulating factor-mobilized marrow harvests and peripheral blood harvests. Wang YT; Zhao XY; Zhao XS; Xu LP; Zhang XH; Wang Y; Liu KY; Chang YJ; Huang XJ Transfusion; 2015 Dec; 55(12):2874-81. PubMed ID: 26261077 [TBL] [Abstract][Full Text] [Related]
2. [CD34 cells and T cell subsets in recombinant human granulocyte colony-stimulating factor primed bone marrow grafts from donors with different characteristics]. Chang YJ; Zhao XY; Huo MR; Luo XH; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):512-6. PubMed ID: 19112912 [TBL] [Abstract][Full Text] [Related]
3. The impact of donor characteristics on the immune cell composition of second allografts in Chinese people. Chen L; Chang YJ; Xu LP; Huang XJ Vox Sang; 2016 Jul; 111(1):101-6. PubMed ID: 26918695 [TBL] [Abstract][Full Text] [Related]
4. The impact of donor characteristics on the invariant natural killer T cells of granulocyte-colony-stimulating factor-mobilized marrow grafts and peripheral blood grafts. Hong Y; Zhao XY; Yu XX; Bian ZL; Chang YJ; Wang Y; Zhang XH; Xu LP; Huang XJ; Zhao XS Transpl Immunol; 2018 Jun; 48():55-59. PubMed ID: 29475092 [TBL] [Abstract][Full Text] [Related]
5. [Effect of bone marrow graft collection on composition of peripheral blood stem cell grafts from healthy donors after recombinant human granulocyte colony-stimulating factor application in vivo for mobilization]. Chang YJ; Zhao XY; Huo MR; Luo XH; Huang XJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):610-3. PubMed ID: 18549639 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics. Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040 [TBL] [Abstract][Full Text] [Related]
7. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests. Li Y; Chang Y; Xu L; Zhang X; Huang X Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236 [TBL] [Abstract][Full Text] [Related]
8. [The effect of granulocyte colony stimulating factor on T-cell subsets in peripheral blood and its correlation with the mobilization effect of CD34+ cells]. Xu J; Lu DP; Ji BX; Wan SG; Sun XJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):639-41. PubMed ID: 14706150 [TBL] [Abstract][Full Text] [Related]
9. [Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts]. Chang YJ; Zhao XY; Huo MR; Huang XJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):146-50. PubMed ID: 19236767 [TBL] [Abstract][Full Text] [Related]
10. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome]. Ji S; Chen H; Wang H; Yan H; Pan S Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675 [TBL] [Abstract][Full Text] [Related]
11. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543 [TBL] [Abstract][Full Text] [Related]
12. [Effects of mobilization with medium dose of rhG-CSF on the immunocyte component of peripheral blood in donors]. Huang WR; Da WM; Deng XL; Gao CJ; Han XP; Wu XX; Li HH; Zhu HY; Jin HJ; Jing Y; Wang SH; Bo J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):852-6. PubMed ID: 16277857 [TBL] [Abstract][Full Text] [Related]
13. [The differences between recombinant human granulocyte colony-stimulating factor-primed and non-primed peripheral blood stem cell harvests]. Liang X; Huang XJ Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):566-8. PubMed ID: 17959081 [TBL] [Abstract][Full Text] [Related]
14. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy. Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816 [TBL] [Abstract][Full Text] [Related]
15. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets. Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø Front Immunol; 2018; 9():845. PubMed ID: 29770133 [TBL] [Abstract][Full Text] [Related]
17. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model. Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478 [TBL] [Abstract][Full Text] [Related]
19. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells. Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors. Rodríguez-Cortés O; Vela-Ojeda J; López-Santiago R; Montiel-Cervantes L; Reyes-Maldonado E; Estrada-García I; Moreno-Lafont MC J Clin Apher; 2010; 25(4):181-7. PubMed ID: 20818712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]